News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
185,815 Results
Type
Article (8493)
Company Profile (39)
Press Release (177275)
Multimedia
Podcasts (17)
Webinars (5)
Section
Business (55979)
Career Advice (170)
Deals (10005)
Drug Delivery (24)
Drug Development (13672)
Employer Resources (20)
FDA (4959)
Job Trends (4266)
News (84993)
Policy (7011)
Tag
Academia (762)
Accelerated approval (32)
Adcomms (8)
Allergies (34)
Alliances (19120)
ALS (66)
Alzheimer's disease (707)
Antibody-drug conjugate (ADC) (134)
Approvals (5005)
Artificial intelligence (383)
Autoimmune disease (44)
Automation (27)
Bankruptcy (57)
Best Places to Work (3684)
BIOSECURE Act (2)
Biosimilars (38)
Biotechnology (27)
Bladder cancer (44)
Brain cancer (26)
Breast cancer (261)
Cancer (1924)
Cardiovascular disease (104)
Career advice (155)
Career pathing (5)
CAR-T (89)
CDC (1)
Celiac Disease (1)
Cell therapy (256)
Cervical cancer (19)
Clinical research (11797)
Collaboration (1016)
Compensation (57)
Complete response letters (9)
COVID-19 (818)
CRISPR (51)
C-suite (352)
Cystic fibrosis (42)
Data (1639)
Decentralized trials (1)
Depression (34)
Diabetes (100)
Diagnostics (6302)
Digital health (32)
Diversity (3)
Diversity, equity & inclusion (4)
Drug discovery (152)
Drug pricing (25)
Drug shortages (6)
Duchenne muscular dystrophy (98)
Earnings (20278)
Editorial (10)
Employer branding (3)
Employer resources (18)
Events (21735)
Executive appointments (383)
FDA (6161)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (4)
Frontotemporal dementia (5)
Funding (817)
Gene editing (85)
Generative AI (36)
Gene therapy (240)
GLP-1 (164)
Government (1234)
Grass and pollen (1)
Guidances (196)
Healthcare (5046)
HIV (24)
Huntington's disease (21)
IgA nephropathy (33)
Immunology and inflammation (51)
Immuno-oncology (16)
Indications (28)
Infectious disease (903)
Inflammatory bowel disease (46)
Inflation Reduction Act (3)
Influenza (35)
Intellectual property (66)
Interviews (23)
IPO (3733)
IRA (5)
Job creations (709)
Job search strategy (133)
JPM (23)
Kidney cancer (6)
Labor market (11)
Layoffs (90)
Leadership (5)
Legal (761)
Liver cancer (22)
Longevity (7)
Lung cancer (244)
Lymphoma (183)
Machine learning (31)
Management (7)
Manufacturing (373)
MASH (55)
Medical device (4145)
Medtech (4168)
Mergers & acquisitions (6744)
Metabolic disorders (265)
Multiple sclerosis (59)
NASH (8)
Neurodegenerative disease (133)
Neuropsychiatric disorders (13)
Neuroscience (1126)
NextGen: Class of 2026 (1431)
Non-profit (1392)
Now hiring (7)
Obesity (102)
Opinion (83)
Ovarian cancer (64)
Pain (47)
Pancreatic cancer (64)
Parkinson's disease (97)
Partnered (16)
Patents (114)
Patient recruitment (125)
Peanut (15)
People (16127)
Pharmaceutical (4)
Pharmacy benefit managers (2)
Phase 1 (3561)
Phase 2 (5023)
Phase 3 (4510)
Pipeline (1959)
Policy (46)
Postmarket research (336)
Preclinical (1345)
Press Release (40)
Prostate cancer (105)
Psychedelics (5)
Radiopharmaceuticals (169)
Rare diseases (294)
Real estate (1597)
Recruiting (8)
Regulatory (6509)
Reports (18)
Research institute (919)
Resumes & cover letters (25)
Rett syndrome (11)
RNA editing (4)
RSV (8)
Schizophrenia (23)
Series A (130)
Series B (99)
Service/supplier (3)
Sickle cell disease (21)
Special edition (6)
Spinal muscular atrophy (35)
Sponsored (14)
Startups (1290)
Stomach cancer (7)
Supply chain (29)
Tariffs (10)
The Weekly (17)
Vaccines (212)
Venture capital (32)
Weight loss (53)
Women's health (29)
Worklife (1)
Date
Today (2)
Last 7 days (203)
Last 30 days (840)
Last 365 days (9985)
2026 (1041)
2025 (10183)
2024 (10713)
2023 (12104)
2022 (17120)
2021 (17797)
2020 (16223)
2019 (12104)
2018 (9047)
2017 (8943)
2016 (8469)
2015 (9309)
2014 (6624)
2013 (5642)
2012 (6123)
2011 (6283)
2010 (5412)
Location
Africa (194)
Alabama (22)
Alaska (2)
Arizona (103)
Arkansas (6)
Asia (11102)
Australia (1958)
California (3193)
Canada (946)
China (361)
Colorado (162)
Connecticut (177)
Delaware (132)
Europe (27140)
Florida (477)
Georgia (95)
Hawaii (2)
Idaho (21)
Illinois (305)
India (25)
Indiana (158)
Iowa (9)
Japan (171)
Kansas (32)
Kentucky (11)
Louisiana (7)
Maine (26)
Maryland (464)
Massachusetts (2252)
Michigan (157)
Minnesota (191)
Mississippi (1)
Missouri (58)
Montana (10)
Nebraska (15)
Nevada (22)
New Hampshire (45)
New Jersey (750)
New Mexico (20)
New York (1171)
North Carolina (524)
North Dakota (9)
Northern California (1571)
Ohio (145)
Oklahoma (11)
Oregon (12)
Pennsylvania (566)
Puerto Rico (3)
Rhode Island (23)
South America (249)
South Carolina (17)
Southern California (1189)
Tennessee (84)
Texas (617)
United States (12352)
Utah (207)
Virginia (117)
Washington D.C. (15)
Washington State (275)
West Virginia (2)
Wisconsin (89)
Wyoming (2)
185,815 Results for "accelerate diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Michael Iskra Appointed CEO of Cleveland Diagnostics to Drive Strategic & Accelerated Growth Following FDA Approval of Its IsoPSA Assay
January 27, 2026
·
3 min read
Insights
From Awareness to Acceleration: Rare Disease Drug Development Enters a Pivotal Era
Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like MPS II moving into the spotlight.
February 4, 2026
·
3 min read
·
Jennifer Smith-Parker
Sponsored
Accelerating Timelines and Reducing Cost in Early Clinical Drug Development With ICON’s Accelerated Pharmaceutical Solutions
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success.
December 8, 2025
·
5 min read
·
Arjen Akkerman
Press Releases
Neurovation Labs Joins NewYorkBIO Fellows Program to Accelerate Development of Biomarker-Driven Neuromedicines and Diagnostics
September 30, 2025
·
2 min read
Gene editing
FDA Eyes Accelerated Reviews for Gene Editing Therapies
Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to outline his office’s thinking on accelerating gene editing reviews.
November 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
The ADDF’s Diagnostics Accelerator Unveils SpeechDx Dataset and New Partnership to Catalyze Breakthroughs in Speech-Based Biomarkers
October 1, 2025
·
5 min read
Press Releases
CS Diagnostics Corp. (OTCQB: CSDX) Accelerates Global Expansion with Key Regulatory Milestones and Record Growth
September 25, 2025
·
4 min read
Press Releases
QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics
June 4, 2025
·
8 min read
Press Releases
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology
Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for Enhanced Diagnostic Capabilities
January 15, 2026
·
4 min read
Press Releases
Bayer Accelerates Pharma Growth on High-Value Portfolio
January 14, 2026
·
13 min read
1 of 18,582
Next
